Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
A-Alpha Bio
3225
A-Alpha Bio
Technology
Biotechnology
Research
AAlpha Bio is revolutionizing preclinical drug development. Our technology enables unprecedented characterization of proteinprotein interactions.
Suggest edits
Type
B2c
Founded
2017
Raised
$1M
Follow us
Also headquartered in Seattle
Amazon
GeekWire
Starbucks
Amazon Web Services
Zillow
Redfin
Tableau
Gates Foundation
Bittrex
Bungie
Companies in the same industry
FluoroFinder
Antibodies.com
QGel
Rytol Pharma
Likarda, LLC
Melanoma Research Alliance
Jabrehoo
Restored Hearing
Beijing Gene+ Technology
New Harvest
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$800,000
Grant - 2020
Bill & Melinda Gates Foundation
$225,000
Grant - 2018
National Science Foundation (NSF)
Team Size
1–10
Employees
I work here
Location
Seattle
,
United States
Headquarters
Explore Seattle
$800,000
Grant
GeekWire
,
neurons.AI
Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research
$225,000
Grant
GeekWire
Clinical drug screening startup A-Alpha Bio awarded Small Business Innovation Research grant
GeekWire
Pre-clinical drug screening startup A-Alpha Bio wins first place at Univ. of Washington Business Plan Competition
Robotics
